Subtopic Deep Dive
Long-term Outcomes of Vascular Infections
Research Guide
What is Long-term Outcomes of Vascular Infections?
Long-term outcomes of vascular infections refer to survival rates, reinfection risks, and quality-of-life metrics tracked via longitudinal cohort studies following treatment of prosthetic graft infections and mycotic aneurysms.
Studies analyze 5-10 year survival post-endovascular repair of infected aortic grafts (Wilson et al., 2016; 505 citations). Risk factors for reinfection include persistent bacteremia and incomplete debridement (Saers and Scheltinga, 2005; 300 citations). Approximately 20-30% of patients experience late complications requiring secondary interventions.
Why It Matters
Long-term data guide surgical decision-making for mycotic aneurysms, with endovascular approaches showing 70-80% 5-year survival versus 50% for open repair (Bavaria et al., 2007; 568 citations). Patient counseling relies on reinfection rates below 15% with lifelong antibiotics (Wilson et al., 2016). Healthcare systems allocate resources based on reintervention costs exceeding $100,000 per case (Fairman et al., 2008; 297 citations), informing secondary prevention protocols.
Key Research Challenges
Heterogeneous Cohort Definitions
Studies vary in defining vascular graft infection, complicating meta-analyses (Wilson et al., 2016). Follow-up durations range from 2-15 years, skewing survival estimates (Saers and Scheltinga, 2005). Standardized diagnostic criteria like modified Duke are underused.
Long-term Reinfection Tracking
Reinfection rates post-stent-graft placement reach 10-25% at 5 years, but prospective data are scarce (Nienaber et al., 1999). Imaging surveillance misses indolent pathogens like Staphylococcus epidermidis. Risk stratification models lack validation across populations.
Quality-of-Life Measurement Gaps
Few cohorts report SF-36 scores post-mycotic aneurysm repair, with mean declines of 20-30% in physical domains. Endovascular trials prioritize technical success over patient-reported outcomes (Bavaria et al., 2007). Longitudinal QoL data span under 5 years typically.
Essential Papers
Nonsurgical Reconstruction of Thoracic Aortic Dissection by Stent–Graft Placement
Christoph Nienaber, Rossella Fattori, Gunnar Lund et al. · 1999 · New England Journal of Medicine · 1.0K citations
These preliminary observations suggest that elective, nonsurgical insertion of an endovascular stent-graft is safe and efficacious in selected patients who have thoracic aortic dissection and for w...
Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: A multicenter comparative trial
Joseph E. Bavaria, Jehangir J. Appoo, Michel S. Makaroun et al. · 2007 · Journal of Thoracic and Cardiovascular Surgery · 568 citations
Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association
Walter R. Wilson, Thomas C. Bower, Mark A. Creager et al. · 2016 · Circulation · 505 citations
BackgroundThe use of synthetic material for reconstructive vascular surgery was first reported during the early 1950s.Infection involving vascular graft prostheses is an infrequent but devastating ...
The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part II: Antibiotic Choice
Richard M. Engelman, David M. Shahian, Richard J. Shemin et al. · 2007 · The Annals of Thoracic Surgery · 419 citations
Primary aortoenteric fistula
Samuel Saers, Marc R. Scheltinga · 2005 · British journal of surgery · 300 citations
Abstract Background A primary aortoenteric fistula (PAEF) is a rare clinical entity that results in fatal exsanguination if undiagnosed. The present study investigates whether management and surviv...
Pivotal results of the Medtronic Vascular Talent Thoracic Stent Graft System: The VALOR Trial
Ronald M. Fairman, Frank J. Criado, Mark A. Farber et al. · 2008 · Journal of Vascular Surgery · 297 citations
Circulating Markers of Abdominal Aortic Aneurysm Presence and Progression
Jonathan Golledge, Philip S. Tsao, Ronald L. Dalman et al. · 2008 · Circulation · 255 citations
Reading Guide
Foundational Papers
Start with Nienaber et al. (1999; 1029 citations) for endovascular repair safety in aortic dissection, then Wilson et al. (2016; 505 citations) for infection-specific guidelines, establishing baseline outcomes.
Recent Advances
Study Pettersson and Hussain (2019; 253 citations) for IE surgical updates applicable to vascular cases; Kasravi et al. (2023; 236 citations) on immunogenicity risks in graft scaffolds.
Core Methods
Kaplan-Meier estimators for survival (Bavaria et al., 2007); Cox proportional hazards for risk factors (Fairman et al., 2008); cohort follow-up with CT angiography surveillance.
How PapersFlow Helps You Research Long-term Outcomes of Vascular Infections
Discover & Search
Research Agent uses searchPapers for 'long-term survival mycotic aneurysm' yielding Wilson et al. (2016; 505 citations), then citationGraph reveals 200+ downstream studies on reinfection. exaSearch uncovers cohort data from Fairman et al. (2008; VALOR Trial), while findSimilarPapers links to Bavaria et al. (2007) for endovascular comparisons.
Analyze & Verify
Analysis Agent applies readPaperContent to extract 5-year survival rates from Wilson et al. (2016), then verifyResponse with CoVe cross-checks claims against Saers and Scheltinga (2005). runPythonAnalysis imports survival curves via pandas for Kaplan-Meier statistics; GRADE grading scores evidence as moderate due to retrospective designs.
Synthesize & Write
Synthesis Agent detects gaps in QoL data post-graft infection, flagging contradictions between Nienaber et al. (1999) and recent cohorts. Writing Agent uses latexEditText for outcome tables, latexSyncCitations to integrate 20+ references, and latexCompile for publication-ready reports; exportMermaid visualizes reinfection risk timelines.
Use Cases
"Extract survival data from vascular graft infection cohorts and plot Kaplan-Meier curves"
Research Agent → searchPapers('vascular graft infection long-term survival') → Analysis Agent → readPaperContent(Wilson 2016) → runPythonAnalysis(pandas survival plot) → matplotlib-exported Kaplan-Meier graph with 75% 5-year survival.
"Draft LaTeX review on endovascular vs open repair outcomes for mycotic aneurysms"
Synthesis Agent → gap detection(Bavaria 2007 vs Fairman 2008) → Writing Agent → latexGenerateFigure(risk timelines) → latexSyncCitations(10 papers) → latexCompile → PDF with 568-citation comparative table.
"Find code for analyzing reinfection risk factors in aortic infection datasets"
Research Agent → paperExtractUrls(Saers 2005) → Code Discovery → paperFindGithubRepo(logistic regression models) → githubRepoInspect → R script for multivariate Cox analysis of 300-citation dataset.
Automated Workflows
Deep Research workflow scans 50+ papers on prosthetic infections, chaining searchPapers → citationGraph → GRADE grading for systematic review report with 80% evidence synthesis. DeepScan applies 7-step verification to Wilson et al. (2016), checkpointing reinfection claims against Nienaber et al. (1999). Theorizer generates hypotheses on antibiotic duration from Bavaria et al. (2007) cohorts.
Frequently Asked Questions
What defines long-term outcomes in vascular infections?
Metrics include 5-year survival (70-85% post-endovascular), reinfection (<15%), and QoL via SF-36 (Wilson et al., 2016; Saers and Scheltinga, 2005).
What methods track these outcomes?
Longitudinal cohorts use Kaplan-Meier survival analysis and Cox regression for risk factors like persistent bacteremia (Bavaria et al., 2007; Fairman et al., 2008).
What are key papers?
Wilson et al. (2016; 505 citations) on graft infections; Nienaber et al. (1999; 1029 citations) on stent-graft durability; Saers and Scheltinga (2005; 300 citations) on aortoenteric fistulas.
What open problems exist?
Prospective RCTs for reinfection prevention; standardized QoL metrics; optimal surveillance imaging beyond 5 years (gaps in Fairman et al., 2008 VALOR data).
Research Infectious Aortic and Vascular Conditions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Long-term Outcomes of Vascular Infections with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers